Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A. R. Meltonyan"'
Autor:
Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, E. A. Ionova, S. E. Arakelov, I. Yu. Titova, A. Yu. Efimtsev, A. R. Meltonyan
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 2, Pp 111-122 (2024)
Background. Chronic liver disease is one of the most common diseases. In many countries, liver disease is among the top five causes of death. The liver is one of the main organs responsible for basic metabolic functions, protein and hormone synthesis
Externí odkaz:
https://doaj.org/article/2efa4af833f244658156aa47f9cf4805
Autor:
Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, A. Yu. Efimtsev, S. E. Arakelov, I. Yu. Titova, A. R. Meltonyan
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 14, Iss 1, Pp 159-167 (2024)
Background. Recently, multiparametric magnetic resonance imaging (MRI) techniques have been developed to stratify clinically significant changes in chronic liver diseases (CLD). The advantage of multiparametric MRI is the visualization of the entire
Externí odkaz:
https://doaj.org/article/685a9ad880804172b379db9464ba2aea
Autor:
T. P. Tuchina, I. A. Kolchanova, A. R. Meltonyan, L. K. Abramyan, A. Yu. Babenko, M. M. Galagudza
Publikováno v:
Медицинский вестник Юга России, Vol 13, Iss 1, Pp 88-97 (2022)
Purpose: evaluate the eff ects of DPP4i on fasting and postprandial insulin and glucagon secretion by examining basal secretion and response to food loading.Materials and methods: patients (n = 54) were divided into treatment groups: long-term (more
Externí odkaz:
https://doaj.org/article/fe8083fed4004b7bb460ff4eff99cdd0
Autor:
M. I. Volkova, A. S. Kalpinskiy, K. V. Men'shikov, L. V. Gorbuleva, O. I. Evsyukova, V. R. Meltonyan, S. V. Mishugin, M. R. Maturov, A. S. Ol'shanskaya, D. Yu. Shemetov, T. A. Sannikova, M. V. Makhnutina, M. A. Filip'eva, E. A. Gaysina, E. G. Ovchinnikova, V. B. Matveev, B. Ya. Alekseev
Publikováno v:
Cancer Urology. 19:46-60
Purpose: an assessment of efficacy and safety of cabozantinib in unselected patients with metastatic renal cell carcinoma in the first and subsequent lines of therapy.Materials and methods. Russian multicenter observational study included 92 consecut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b8db556917456a14462e91419bafd78
https://doi.org/10.17650/1726-9776-2023-19-1-46-60
https://doi.org/10.17650/1726-9776-2023-19-1-46-60